← Back to Search

Behavioral Intervention

DBT for Borderline Personality Disorder (FASTER-DBT Trial)

N/A
Waitlist Available
Led By Shelley McMain, Ph.D
Research Sponsored by Centre for Addiction and Mental Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at pre-treatment and every three months over 24 months
Awards & highlights

Summary

"This trial will compare the effectiveness and cost-effectiveness of one year versus six months of dialectical behaviour therapy (DBT) for individuals with borderline personality disorder. The study aims to determine if a shorter

Who is the study for?
This trial is for individuals with Borderline Personality Disorder who have self-harmed at least twice in the last five years, once within the past eight weeks. Participants must speak English, consent to join, not have had extensive DBT therapy recently, and live in specific areas of Canada with local health insurance.
What is being tested?
The study tests if a shorter 6-month Dialectical Behaviour Therapy (DBT) program is as effective and cost-efficient as the standard one-year program for reducing self-harm in people with BPD. Patients are randomly placed into two groups to compare outcomes over two years.
What are the potential side effects?
Since DBT is a type of psychotherapy involving talk therapy and skills training rather than medication, it does not have traditional side effects like drugs do. However, participants may experience emotional discomfort or distress during sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at pre-treatment and every three months over 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at pre-treatment and every three months over 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in frequency of self-harm (suicidal and non-suicidal) behaviours over time as measured by the Suicide Attempt Self-Injury Interview (SASII)
Secondary study objectives
Change in BPD symptoms as measured by the Borderline Symptom List-23 (BSL-23)
Change in anger as measured by the State-Trait Anger Expression Inventory-2 (STAXI-2)
Change in depression as measured by the Beck Depression Inventory-II (BDI-II)
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Dialectical Behaviour Therapy-6 monthsExperimental Treatment1 Intervention
6 months of standard dialectical behaviour therapy treatment.
Group II: Dialectical Behaviour Therapy-12 monthsActive Control1 Intervention
12 months of standard dialectical behaviour therapy treatment

Find a Location

Who is running the clinical trial?

Simon Fraser UniversityOTHER
57 Previous Clinical Trials
10,448 Total Patients Enrolled
Centre for Addiction and Mental HealthLead Sponsor
367 Previous Clinical Trials
82,146 Total Patients Enrolled
5 Trials studying Borderline Personality Disorder
655 Patients Enrolled for Borderline Personality Disorder
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,377 Previous Clinical Trials
26,513,385 Total Patients Enrolled
1 Trials studying Borderline Personality Disorder
180 Patients Enrolled for Borderline Personality Disorder
~8 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top